Report Detail

Pharma & Healthcare Global Flunixin Meglumine Injection Market Research Report 2021

  • RnM4326664
  • |
  • 24 June, 2021
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Flunixin Meglumine Injection Market Overview

  • 1.1 Product Overview and Scope of Flunixin Meglumine Injection
  • 1.2 Flunixin Meglumine Injection Segment by Type
    • 1.2.1 Global Flunixin Meglumine Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 10ml/Dose
    • 1.2.3 20ml/ Dose
  • 1.3 Flunixin Meglumine Injection Segment by Application
    • 1.3.1 Global Flunixin Meglumine Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Animal muscle pain
    • 1.3.3 Animal febrile disease
    • 1.3.4 Others
  • 1.4 Global Flunixin Meglumine Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Flunixin Meglumine Injection Revenue 2016-2027
    • 1.4.2 Global Flunixin Meglumine Injection Sales 2016-2027
    • 1.4.3 Flunixin Meglumine Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Flunixin Meglumine Injection Market Competition by Manufacturers

  • 2.1 Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Flunixin Meglumine Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Flunixin Meglumine Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Flunixin Meglumine Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Flunixin Meglumine Injection Market Competitive Situation and Trends
    • 2.5.1 Flunixin Meglumine Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Flunixin Meglumine Injection Players Market Share by Revenue
    • 2.5.3 Global Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Flunixin Meglumine Injection Retrospective Market Scenario by Region

  • 3.1 Global Flunixin Meglumine Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Flunixin Meglumine Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Flunixin Meglumine Injection Market Facts & Figures by Country
    • 3.3.1 North America Flunixin Meglumine Injection Sales by Country
    • 3.3.2 North America Flunixin Meglumine Injection Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Flunixin Meglumine Injection Market Facts & Figures by Country
    • 3.4.1 Europe Flunixin Meglumine Injection Sales by Country
    • 3.4.2 Europe Flunixin Meglumine Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Flunixin Meglumine Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Flunixin Meglumine Injection Sales by Region
    • 3.5.2 Asia Pacific Flunixin Meglumine Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Flunixin Meglumine Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Flunixin Meglumine Injection Sales by Country
    • 3.6.2 Latin America Flunixin Meglumine Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Flunixin Meglumine Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Flunixin Meglumine Injection Sales by Country
    • 3.7.2 Middle East and Africa Flunixin Meglumine Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Flunixin Meglumine Injection Historic Market Analysis by Type

  • 4.1 Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Flunixin Meglumine Injection Price by Type (2016-2021)

5 Global Flunixin Meglumine Injection Historic Market Analysis by Application

  • 5.1 Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Flunixin Meglumine Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Flunixin Meglumine Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Norbrook
    • 6.1.1 Norbrook Corporation Information
    • 6.1.2 Norbrook Description and Business Overview
    • 6.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Norbrook Flunixin Meglumine Injection Product Portfolio
    • 6.1.5 Norbrook Recent Developments/Updates
  • 6.2 Zoteis
    • 6.2.1 Zoteis Corporation Information
    • 6.2.2 Zoteis Description and Business Overview
    • 6.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Zoteis Flunixin Meglumine Injection Product Portfolio
    • 6.2.5 Zoteis Recent Developments/Updates
  • 6.3 Merck Animal Health
    • 6.3.1 Merck Animal Health Corporation Information
    • 6.3.2 Merck Animal Health Description and Business Overview
    • 6.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
    • 6.3.5 Merck Animal Health Recent Developments/Updates
  • 6.4 Virbac Animal Health India Private Limited
    • 6.4.1 Virbac Animal Health India Private Limited Corporation Information
    • 6.4.2 Virbac Animal Health India Private Limited Description and Business Overview
    • 6.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
    • 6.4.5 Virbac Animal Health India Private Limited Recent Developments/Updates
  • 6.5 MSD Animal Health
    • 6.5.1 MSD Animal Health Corporation Information
    • 6.5.2 MSD Animal Health Description and Business Overview
    • 6.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
    • 6.5.5 MSD Animal Health Recent Developments/Updates
  • 6.6 Bengal Remedies Limited
    • 6.6.1 Bengal Remedies Limited Corporation Information
    • 6.6.2 Bengal Remedies Limited Description and Business Overview
    • 6.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
    • 6.6.5 Bengal Remedies Limited Recent Developments/Updates
  • 6.7 Wuhan Huisheng Biological Technology Co., Ltd.
    • 6.6.1 Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
    • 6.6.2 Wuhan Huisheng Biological Technology Co., Ltd. Description and Business Overview
    • 6.6.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
  • 6.8 Qilu Animal Health Products Co., Ltd.
    • 6.8.1 Qilu Animal Health Products Co., Ltd. Corporation Information
    • 6.8.2 Qilu Animal Health Products Co., Ltd. Description and Business Overview
    • 6.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.8.5 Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
  • 6.9 Baimukang Animal Pharmaceutical Co., Ltd.
    • 6.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
    • 6.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Description and Business Overview
    • 6.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
    • 6.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Corporation Information
    • 6.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Description and Business Overview
    • 6.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
  • 6.11 Hebei New Century Pharmaceutical Co., Ltd.
    • 6.11.1 Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
    • 6.11.2 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
    • 6.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
    • 6.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
    • 6.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
    • 6.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.13 Shandong Lukang Pharmaceutical Co., Ltd.
    • 6.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
    • 6.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
    • 6.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
    • 6.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates

7 Flunixin Meglumine Injection Manufacturing Cost Analysis

  • 7.1 Flunixin Meglumine Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Flunixin Meglumine Injection
  • 7.4 Flunixin Meglumine Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Flunixin Meglumine Injection Distributors List
  • 8.3 Flunixin Meglumine Injection Customers

9 Flunixin Meglumine Injection Market Dynamics

  • 9.1 Flunixin Meglumine Injection Industry Trends
  • 9.2 Flunixin Meglumine Injection Growth Drivers
  • 9.3 Flunixin Meglumine Injection Market Challenges
  • 9.4 Flunixin Meglumine Injection Market Restraints

10 Global Market Forecast

  • 10.1 Flunixin Meglumine Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Flunixin Meglumine Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Flunixin Meglumine Injection by Type (2022-2027)
  • 10.2 Flunixin Meglumine Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Flunixin Meglumine Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Flunixin Meglumine Injection by Application (2022-2027)
  • 10.3 Flunixin Meglumine Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Flunixin Meglumine Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Flunixin Meglumine Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    10ml/Dose
    20ml/ Dose

    Segment by Application
    Animal muscle pain
    Animal febrile disease
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Norbrook
    Zoteis
    Merck Animal Health
    Virbac Animal Health India Private Limited
    MSD Animal Health
    Bengal Remedies Limited
    Wuhan Huisheng Biological Technology Co., Ltd.
    Qilu Animal Health Products Co., Ltd.
    Baimukang Animal Pharmaceutical Co., Ltd.
    Shandong Zhongmu Veterinary Medicine Co., Ltd.
    Hebei New Century Pharmaceutical Co., Ltd.
    Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
    Shandong Lukang Pharmaceutical Co., Ltd.


    Summary:
    Get latest Market Research Reports on Flunixin Meglumine Injection. Industry analysis & Market Report on Flunixin Meglumine Injection is a syndicated market report, published as Global Flunixin Meglumine Injection Market Research Report 2021. It is complete Research Study and Industry Analysis of Flunixin Meglumine Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,108.30
    3,162.45
    4,216.60
    2,462.10
    3,693.15
    4,924.20
    320,392.00
    480,588.00
    640,784.00
    215,905.00
    323,857.50
    431,810.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report